THNK Share Price Performance

THNK Community Fair Values

View all narratives

Recent THNK News & Updates

No updates

Think Research Corporation Key Details

Last Reported Earnings

Sep 30, 2023

Next Reporting Earnings

n/a

Earnings per share (EPS): -0.19
Gross Margin: 49.33%
Net Profit Margin: -18.02%
Debt/Equity Ratio: 149.2%

View full report ›

Think Research Corporation Competitors

About THNK

Founded: n/a
Employees: n/a
CEO: Sachin Aggarwal
WebsiteView website: www.thinkresearch.com/ca/

Think Research Corporation provides knowledge-based digital health software solutions in Canada, the United States, and internationally. The company’s products portfolio comprises order sets that structures clinical pathway at the point of care; eReferrals that allows physicians to find and refer specialists directly from EMR systems; Digital Front Door, a patient engagement platform that enables healthcare organizations to provide access to care and health information through a single digital service window; VirtualCare, which allows clinicians and allied health professionals to replace in-person appointments with virtual visits; and eForms, a real-time analytics to track resident volumes, signature adherence, and compliance; and COVID-19 clinical tools, as well as clinical support tools for long-term care. Think Research Corporation is based in Toronto, Canada.

Canadian Market Performance

0.7%

13.4%

17.8%

9.9%

Over the last 7 days, the market has remained flat, although notably the Healthcare sector declined by 4.0%. As for the longer term, the market has risen 18% in the past 12 months. Looking forward, earnings are forecast to grow by 12% annually. Market details ›

Think Research Stock Price

THNK Share Price Performance

THNK Community Fair Values

Recent THNK News & Updates

Think Research Corporation Key Details

Think Research Corporation Competitors

ASEP Medical Holdings

nDatalyze

Empatho Holdings

CardioComm Solutions

Ventripoint Diagnostics

Justera Health

Kovo+ Holdings

Cloud DX

🇪🇺 🇬🇧 Momentum Is Returning to European and UK Markets

The Big Beautiful Deficit